Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Long-lasting, unexplained and asymptomatic blood hypereosinophilia.
No clinical trials have been registered for hypereosinophilia of undetermined significance.
3 publications have been identified in PubMed for hypereosinophilia of undetermined significance. Research spans Review / Meta-Analysis (33%), Case Report / Case Series (33%), and Epidemiology / Natural History (33%).
Lipsker D (2025). [PMID: 40277217](https://pubmed.ncbi.nlm.nih.gov/40277217/). *J Eur Acad Dermatol Venereol*. [Review / Meta-Analysis]
Stammler R (2025). [PMID: 40992688](https://pubmed.ncbi.nlm.nih.gov/40992688/). *J Allergy Clin Immunol Pract*. [Epidemiology / Natural History]
Kondo RN (2024). [PMID: 38658243](https://pubmed.ncbi.nlm.nih.gov/38658243/). *An Bras Dermatol*. [Case Report / Case Series]
Data assembled from 2 of 12 sources · Last updated Oct 4, 2026, 12:14 AM UTC
AI-curated news mentioning hypereosinophilia of undetermined significance
Updated Sep 1, 2026
A new publication discusses eosinophilia and hypereosinophilia, providing a practical approach to navigating their broad differential diagnosis. This resource may aid clinicians in identifying underlying causes and managing these conditions effectively.